These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3010334)

  • 1. Opioid-receptor blockade reduces nose-poke self-stimulation derived from medial entorhinal cortex.
    Reymann KG; Wulcko S; Ott T; Matthies H
    Pharmacol Biochem Behav; 1986 Mar; 24(3):439-43. PubMed ID: 3010334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis.
    McGregor IS; Atrens DM; Jackson DM
    Psychopharmacology (Berl); 1992; 106(2):239-47. PubMed ID: 1312730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone suppression of self-stimulation is independent of response difficulty.
    Trujillo KA; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1989 May; 33(1):147-55. PubMed ID: 2675125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of reward by hunger is opioid mediated.
    Carr KD; Simon EJ
    Brain Res; 1984 Apr; 297(2):369-73. PubMed ID: 6326944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the work requirements lowers the threshold of naloxone for reducing self-stimulation in the midbrain of rats.
    West CH; Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1983 May; 18(5):705-10. PubMed ID: 6856645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Life Sci; 1985 Jul; 37(2):169-76. PubMed ID: 2989642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific naloxone blockade of brain self-stimulation duration.
    Freedman NL; Pangborn D
    Pharmacol Biochem Behav; 1984 Mar; 20(3):361-6. PubMed ID: 6608735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial thalamic injection of opioid agonists: mu-agonist increases while kappa-agonist decreases stimulus thresholds for pain and reward.
    Carr KD; Bak TH
    Brain Res; 1988 Feb; 441(1-2):173-84. PubMed ID: 2833999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
    Millan MJ; Colpaert FC
    Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain endorphins: possible role in reward and memory formation.
    Stein L; Belluzzi JD
    Fed Proc; 1979 Oct; 38(11):2468-72. PubMed ID: 39791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel class of central reward sites showing a delayed and cumulative response to opiate blockade.
    Katz RJ
    Pharmacol Biochem Behav; 1981 Jul; 15(1):131-4. PubMed ID: 6974870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical self-stimulation of dentate gyrus granule cells.
    Collier TJ; Routtenberg A
    Behav Neural Biol; 1984 Sep; 42(1):85-90. PubMed ID: 6095804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit.
    Trujillo KA; Belluzzi JD; Stein L
    Brain Res; 1989 Jul; 492(1-2):15-28. PubMed ID: 2752295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioids and the first suckling episode in the rat.
    Petrov ES; Varlinskaya EI; Smotherman WP
    Dev Psychobiol; 1998 Sep; 33(2):175-83. PubMed ID: 9742412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does naloxone suppress self-stimulation by decreasing reward or by increasing aversion?
    Kelsey JE; Belluzzi JD; Stein L
    Brain Res; 1984 Jul; 307(1-2):55-9. PubMed ID: 6467008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum.
    Panagis G; Kastellakis A; Spyraki C
    Psychopharmacology (Berl); 1998 Oct; 139(3):222-9. PubMed ID: 9784077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous naloxone administration on ventral tegmental self-stimulation.
    Hawkins M; Stein EA
    Brain Res; 1991 Sep; 560(1-2):315-20. PubMed ID: 1662111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.